Federal Register Notice: FDA’s Dermatologic and Ophthalmic Drugs Advisory Committee and the Drug Safety and Risk Management Advisory Committee will meet 8/1, from 8 a.m. to 12:30 p.m. at the Hilton Washington DC North/Gaithersburg, The Ballrooms, 620 Perry Pkwy, Gaithersburg, MD. The committees will meet to be briefed on iPLEDGE, the risk management program for isotretinoin products. Contact Sohail Mosaddegh, (301) 827-7001. To view this notice, click here.
